...
search icon
dcoy-img

Decoy Therapeutics Inc. Share Price

DCOY
NAQ
$0.7388
-$0.01
(-1.33%)
1D

Decoy Therapeutics Inc. Analyst Forecast

Decoy Therapeutics Inc. Share Price Chart

Decoy Therapeutics Inc. Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$4.79M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
79.24K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.52 L
$1.41 H
$0.7388

About Decoy Therapeutics Inc., Common Stock

Decoy Therapeutics Inc. focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that reduces the complexity of drug development and manufacturing. Its IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, optimize, and manufacture peptide conjugates targeting various unmet medical needs. The company focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology. The company was formerly known as Salarius Pharmaceuticals, Inc. and change its name to Decoy Therapeutics Inc. in January 2026. Decoy Therapeutics Inc. is based in Cambridge, Massachusetts. more

Decoy Therapeutics Inc. Stock Returns

Data is not properly formatted.

Decoy Therapeutics Inc. Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue5.23M1.84M---[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":35.16,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue-19.18K6.68K10.05K4.42K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":34.81,"profit":true},{"date":"2023-12-31","value":52.4,"profit":true},{"date":"2024-12-31","value":23.06,"profit":true}]
Gross Profit5.23M1.82M(6.68K)(10.05K)(4.42K)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":34.8,"profit":true},{"date":"2022-12-31","value":-0.13,"profit":false},{"date":"2023-12-31","value":-0.19,"profit":false},{"date":"2024-12-31","value":-0.08,"profit":false}]
Gross Margin100.00%98.96%---[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":98.96,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses13.02M12.81M31.84M12.89M5.73M[{"date":"2020-12-31","value":40.89,"profit":true},{"date":"2021-12-31","value":40.24,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":40.5,"profit":true},{"date":"2024-12-31","value":18.01,"profit":true}]
Operating Income(7.79M)(12.81M)(31.84M)(12.89M)(5.73M)[{"date":"2020-12-31","value":-778634500,"profit":false},{"date":"2021-12-31","value":-1281293100,"profit":false},{"date":"2022-12-31","value":-3184114000,"profit":false},{"date":"2023-12-31","value":-1289494400,"profit":false},{"date":"2024-12-31","value":-573431600,"profit":false}]
Total Non-Operating Income/Expense--451.91K704.50K317.08K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":64.15,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":45.01,"profit":true}]
Pre-Tax Income(7.35M)(12.77M)(31.61M)(12.54M)(5.58M)[{"date":"2020-12-31","value":-735225400,"profit":false},{"date":"2021-12-31","value":-1276823800,"profit":false},{"date":"2022-12-31","value":-3160795600,"profit":false},{"date":"2023-12-31","value":-1254269300,"profit":false},{"date":"2024-12-31","value":-557577700,"profit":false}]
Income Taxes-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations-(12.77M)(31.61M)(12.54M)(5.58M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-1276823800,"profit":false},{"date":"2022-12-31","value":-3160795600,"profit":false},{"date":"2023-12-31","value":-1254269300,"profit":false},{"date":"2024-12-31","value":-557577700,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(7.35M)(12.77M)(31.61M)(12.54M)(5.58M)[{"date":"2020-12-31","value":-735225400,"profit":false},{"date":"2021-12-31","value":-1276823800,"profit":false},{"date":"2022-12-31","value":-3160795600,"profit":false},{"date":"2023-12-31","value":-1254269300,"profit":false},{"date":"2024-12-31","value":-557577700,"profit":false}]
EPS (Diluted)(0.55)(0.30)(345.88)(278.93)(97.04)[{"date":"2020-12-31","value":-55,"profit":false},{"date":"2021-12-31","value":-30,"profit":false},{"date":"2022-12-31","value":-34588.37,"profit":false},{"date":"2023-12-31","value":-27892.93,"profit":false},{"date":"2024-12-31","value":-9704.28,"profit":false}]

Decoy Therapeutics Inc. Ratios

Decoy Therapeutics Inc. Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

DCOY
Cash Ratio 4.36
Current Ratio 5.49

Decoy Therapeutics Inc. Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

DCOY
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Decoy Therapeutics Inc. Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

DCOY
Debt Ratio Lower is generally better. Negative is bad. 0.30
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.70

Decoy Therapeutics Inc. Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

DCOY
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.00
EV/R 0.00
EV/Ebitda NM

FAQs

What is Decoy Therapeutics Inc. share price today?

Decoy Therapeutics Inc. (DCOY) share price today is $0.7388

Can Indians buy Decoy Therapeutics Inc. shares?

Yes, Indians can buy shares of Decoy Therapeutics Inc. (DCOY) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DCOY stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Decoy Therapeutics Inc. be purchased?

Yes, you can purchase fractional shares of Decoy Therapeutics Inc. (DCOY) via the Vested app. You can start investing in Decoy Therapeutics Inc. (DCOY) with a minimum investment of $1.

How to invest in Decoy Therapeutics Inc. shares from India?

You can invest in shares of Decoy Therapeutics Inc. (DCOY) via Vested in three simple steps:

  • Click on Sign Up or Invest in DCOY stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Decoy Therapeutics Inc. shares
What is Decoy Therapeutics Inc. 52-week high and low stock price?

The 52-week high price of Decoy Therapeutics Inc. (DCOY) is $1.41. The 52-week low price of Decoy Therapeutics Inc. (DCOY) is $0.52.

What is Decoy Therapeutics Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Decoy Therapeutics Inc. (DCOY) is

What is Decoy Therapeutics Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Decoy Therapeutics Inc. (DCOY) is 0.00

What is Decoy Therapeutics Inc. dividend yield?

The dividend yield of Decoy Therapeutics Inc. (DCOY) is 0.00%

What is the Market Cap of Decoy Therapeutics Inc.?

The market capitalization of Decoy Therapeutics Inc. (DCOY) is $4.79M

What is Decoy Therapeutics Inc.'s stock symbol?

The stock symbol (or ticker) of Decoy Therapeutics Inc. is DCOY

How Can Investors Use Decoy Therapeutics Inc. Share Price Data for Long-Term Investment Decisions?

Consider the share price of Decoy Therapeutics Inc. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Decoy Therapeutics Inc. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Decoy Therapeutics Inc. shares for Indian investors?

When investing in Decoy Therapeutics Inc. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Decoy Therapeutics Inc. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Decoy Therapeutics Inc. share price with other stocks in the same sector?

Rather than merely checking the share price of Decoy Therapeutics Inc. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Decoy Therapeutics Inc. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top